Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Provident Financial Services
PFS
$3.24B
| $592K | ﹤0.01% |
40,675
+1
| +0% | +$16 |
|
1927
Live Oak Bancshares
LOB
$1.97B
| $590K | ﹤0.01% |
14,233
| – | – |
|
1928
OneSpaWorld
OSW
$2.64B
| $587K | ﹤0.01% |
44,403
+19
| +0% | +$257 |
|
1929
Peloton Interactive
PTON
$2.76B
| $585K | ﹤0.01% |
136,584
+37
| +0% | +$183 |
|
1930
National Healthcare
NHC
$3.58B
| $584K | ﹤0.01% |
6,160
| – | – |
|
1931
Ironwood Pharmaceuticals
IRWD
$614M
| $583K | ﹤0.01% |
66,977
+4
| +0% | +$49 |
|
1932
Hertz
HTZ
$524M
| $578K | ﹤0.01% |
73,886
-39
| -0.1% | -$319 |
|
|
ARR
1933
Armour Residential REIT
ARR
$2.33B
| $578K | ﹤0.01% |
29,240
+2
| +0% | +$38 |
|
1934
Claros Mortgage Trust
CMTG
$257M
| $575K | ﹤0.01% |
58,966
+3
| +0% | +$32 |
|
1935
Nelnet
NNI
$4.88B
| $575K | ﹤0.01% |
6,073
+1
| +0% | +$88 |
|
1936
Hawaiian Electric Industries
HE
$2.28B
| $573K | ﹤0.01% |
50,854
+4
| +0% | +$51 |
|
1937
The Joint Corp
JYNT
$119M
| $572K | ﹤0.01% |
43,830
-1,828
| -4% | -$18.9K |
|
1938
MiMedx Group
MDXG
$622M
| $569K | ﹤0.01% |
74,145
-118
| -0.2% | -$948 |
|
1939
Hagerty
HGTY
$1.17B
| $568K | ﹤0.01% |
62,079
-4,773
| -7% | -$40K |
|
1940
MoonLake Immunotherapeutics
MLTX
$1.62B
| $567K | ﹤0.01% |
11,287
+65
| +0.6% | +$3.53K |
|
1941
SEI Investments
SEIC
$12.4B
| $565K | ﹤0.01% |
7,864
-743
| -9% | -$49.4K |
|
1942
Chefs' Warehouse
CHEF
$4.58B
| $564K | ﹤0.01% |
14,980
| – | – |
|
1943
Schneider National
SNDR
$5.98B
| $564K | ﹤0.01% |
24,902
-94
| -0.4% | -$2.23K |
|
1944
Universal Corp
UVV
$1.33B
| $563K | ﹤0.01% |
10,885
+1
| +0% | +$54 |
|
1945
Amalgamated Financial
AMAL
$1.48B
| $562K | ﹤0.01% |
23,410
-1,721
| -7% | -$42.3K |
|
1946
Old Second Bancorp
OSBC
$1.29B
| $561K | ﹤0.01% |
40,563
-2,524
| -6% | -$35.3K |
|
1947
Employers Holdings
EIG
$941M
| $561K | ﹤0.01% |
12,372
+1
| +0% | +$43 |
|
|
NVEE
1948
DELISTED
NV5 Global
NVEE
| $560K | ﹤0.01% |
22,864
+4
| +0% | +$104 |
|
1949
RxSight
RXST
$252M
| $559K | ﹤0.01% |
10,854
+10
| +0.1% | +$491 |
|
1950
Scholastic
SCHL
$789M
| $558K | ﹤0.01% |
14,802
-6
| -0% | -$230 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.